Valion Bio (VBIO) Non Operating Income (2021 - 2025)

Valion Bio has reported Non Operating Income for 4 years, with the latest figure at -$113000.0 in Q3 2025.

• On a quarterly basis, Non Operating Income changed N/A year-over-year to -$113000.0 in Q3 2025; TTM through Sep 2025 was -$100000.0, a 72.41% decrease from a year earlier, with the FY2024 full-year figure at $6000.0, up 500.0% from the prior year.
• Non Operating Income was -$113000.0 for Q3 2025 at Valion Bio, down from $3000.0 in the prior quarter.
• The five-year high for Non Operating Income was $6000.0 in Q4 2024, with the low at -$1.4 million in Q4 2021.
• Average Non Operating Income over 4 years is -$274363.6, with a median of -$39000.0 recorded in 2021.
• The sharpest annual moves came in 2022 and 2025: Non Operating Income jumped 100.14% in 2022, then surged 105.0% in 2025.
• Over 4 years, Non Operating Income stood at -$1.4 million in 2021, then surged by 100.14% to $2000.0 in 2022, then jumped by 200.0% to $6000.0 in 2024, then sank by 1983.33% to -$113000.0 in 2025.
• The last three Non Operating Income figures came in at -$113000.0 (Q3 2025), $3000.0 (Q2 2025), and $4000.0 (Q1 2025), per Business Quant data.